维普期刊资源整合服务平台（V6.5）

230篇 您的检索式：作者名="Verstuyft"

选中清除导出查看参考文献查看引证文献引用追踪共12页首页上一页第1页下一页末页 /12 跳转

	题名	作者	年代	出处	被引量
1	Frequency of cytochrome P450 2(29 allelic variants in the Chinese and French populations显示文摘	Yang JQ Morin S Verstuyft C	2003	Fundam Clin Pharmacol2003，17，3：	1
2	Genetic determinants of response to clopidogrel and cardiovascular events 显示文摘	Simon T Verstuyft C Mary-Kranse M	2009	N Engl J Med2009，360，4：	1
3	Genetic determinants of response to clopidogrel and cardiovascular events 显示文摘	Simon T Verstuyft C Mary-Krause M	2009	N Engl J Med2009，360，：	1
4	Association of MDRI SNP with tacrolimus dose requirements in renal transplant recipients 显示文摘	ANGLICHEAU D VERSTUYFT C	2003	J Am Soc Nephrol2003，14，：	1
5	Cytochrome P4502C9(CYP2C9) and Vitamin Z epoxide reductase(VKORC1)genotypes as determinants of acenocoumarol sensitivity显示文摘	Bodin L Verstuyft C Tregouet DA	2005	Blood2005，106，：	1
6	Genetic de- terminants of response to clopidogrel and cardiovascular events显示文摘	Simon T Verstuyft C Mary-Krause M	2009	N Engl J Med2009，360，4：	1
7	Cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase ( VKORC1 ) genotypes as determinants of acenocoumarol sensitivity显示文摘	Bodin L Verstuyft C Tregouet DA	2005	Blood2005，106，1：	1
8	Genetic determinants of response to clopidogrel and cardiovascular events显示文摘	Simon T Verstuyft C Mary-Krause M	2009	N Engl J Med2009，360，4：	1
9	Cytochrome P4502C9 (CYP2C9)and vitamin K epoxide reductase (VKOR- CO) genotypes as determinants of acenocoumaml sensitivity显示文摘	BODIN L VERSTUYFT C TREGOUET D A	2005	Blood2005，1，106：	1
10	Cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase( VKORC1 ) genotypes as determinants of acenocoumarol sensitivity显示文摘	Bodin L Verstuyft C Tregouet DA	2005	Blood2005，106，1：	1
11	Genetic determinants of re-sponse to clopidogrel and cardiovascular events 显示文摘	Simon T Verstuyft C Mary-Krause M	2009	N Engl J Med2009，360，360：	1
12	Association of the multidrug resistance-1 gene single nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients显示文摘	Anglicheau D Verstuyft C Laurentpuig P	2003	J Am Soc Nephrol2003，14，7：	1
13	Association of the muhidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients 显示文摘	Anglicheau D Verstuyft C Laurent-Puig P	2003	JAm Soc Nephrol2003，14，7：	1
14	Genetic Determinants of response to Clopidogrel and cardiovascular events 显示文摘	Simon T Verstuyft C Mary - Krause M	2009	N Engl J Med2009，360，4：	1
15	Genetic determinants of response toclopidogrelandcardiovascularevents显示文摘	Simon T Verstuyft C Mary-Krause M	2009	NEnglJMed2009，360，：	1
16	Genetic determinants of response to clopidogrel and cardiovascular events显示文摘	Simon T Verstuyft C Mary-Krause M	2009	N Engl J Med2009，360，4：	1
17	Genetic determi- nants of response to clopidogrel and cardiovascular events 显示文摘	Simon T Verstuyft C Mary-Krause M	2009	N Engl J Med2009，360，4：	1
18	Genetic Determinants of response to Clopidogrel and cardiovascular events显示文摘	Simon T Verstuyft C Mary-Krause M	2009	New Engl J Med2009，360，4：	1
19	Human multidrug and toxin extrusion 1 ( MATE1/SLC47A1 ) transporter:functional characterization,interaction with OCT2 ( SLC22A2), and single nucleotide polymorphisms 显示文摘	Meyer zu Schwabedissen HE Verstuyft C Kroemer HK	2010	Am J Physiol Renal Physiol2010，298，4：	1
20	Genetic determinants of response to clopidogrel and cardiovascular events显示文摘	SIMON T VERSTUYFT C MARY-KRAUSE M	2009	N Engl JMed2009，360，4：	1

返回顶部每页显示：

共12页首页上一页第1页下一页末页 /12 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示